Universal Healthcare and Single-Payer: What Each Position Is Protecting

In 2023, the United States spent approximately $4.9 trillion on healthcare — roughly 17.6 percent of GDP, more per capita than any other country on earth. Americans paid more for hospital care, more for prescription drugs, more for physician services, and more in administrative overhead than citizens of any comparable nation. And yet in 2024, 27.1 million Americans had no health insurance for the entire year. Millions more were "underinsured" — technically covered but one serious diagnosis away from financial catastrophe. A 2022 analysis found that approximately 41 percent of American adults, roughly 100 million people, carried medical debt.

The comparison is almost impossible to process: Germany provides universal coverage through regulated employment-based insurance funds at roughly 12 percent of GDP. Canada's single-payer system covers everyone at about 13 percent. Taiwan moved from 40 percent uninsured to universal coverage in two years, in 1995, by adopting a single-payer system modeled explicitly on Medicare. The United Kingdom runs the National Health Service — a fully public system, not just public insurance — at about 12 percent of GDP. Every wealthy country except the United States has found a way to cover its entire population for less money than the United States spends leaving tens of millions uncovered.

This is the fact that makes the American healthcare debate so strange from the outside and so volatile from the inside. The question is not whether universal coverage is possible — every peer nation has achieved it. The question is why the United States has not, and what each position in the debate understands about that failure that the others miss.

In the healthcare cluster, this is the point where the larger market-versus-obligation conflict becomes institutional design. The access map asks whether being priced out of care is a tolerable outcome. This map asks where that answer has to live in the payment architecture itself. If healthcare is a public obligation, should that obligation be embodied in one public payer, in a public competitor disciplining private plans, in a tightly regulated multi-payer structure, or in market rules that preserve consumer choice while trying to soften exclusion at the edges? The financing debate matters because it is where moral language turns into durable incentives.

What single-payer advocates are protecting

The proposition that health insurance administered by private companies whose core obligation is to shareholders is structurally incompatible with the goal of providing healthcare to everyone who needs it — and that if healthcare is genuinely a public obligation, that obligation has to be built into the financing layer itself rather than patched back in after market sorting has already happened. Physicians for a National Health Program, which has advocated for single-payer since 1987, argues that the problem is not how private insurance is regulated but what it is for. A private insurer's business model depends on collecting more in premiums than it pays out in claims. This creates a structural incentive to deny coverage, limit benefits, cherry-pick healthy enrollees, and build administrative apparatuses to contest claims. The ACA required that insurers spend at least 80 percent of premiums on medical care — but that left 20 percent for administration, profit, marketing, and executive compensation. In traditional Medicare, administrative overhead runs at approximately 2 percent. The gap represents not waste but a feature: private insurance administration exists to perform functions — prior authorization, claims adjudication, network management, billing — that a single-payer system renders unnecessary. The administrative savings alone, estimated by PNHP at over $500 billion annually, would be sufficient to cover every uninsured American with money left over.

The specific moral claim that health outcomes are distributed along lines of employment, race, and wealth in ways that no market-adjacent system can fully correct — and that only a universal guarantee, with no tiering by ability to pay, can honor the premise that human lives have equal worth. The United States has some of the widest health outcome disparities among wealthy nations. Black Americans die from preventable cardiovascular disease at rates significantly higher than white Americans. Americans without college degrees have mortality rates comparable to citizens of countries with far lower incomes. The connection between insurance coverage and health outcomes is not incidental: a 2009 Harvard study estimated that lack of health insurance was associated with approximately 45,000 preventable deaths annually; subsequent analyses have produced estimates in the range of 60,000 to 68,000. Single-payer advocates point out that these deaths are not random. They are concentrated among people who are poor, Black, Latino, and rural — populations for whom the job-based insurance system offers the least protection. What the single-payer position protects is the recognition that healthcare rationed by employment and income is healthcare that has been assigned a price, and that the price is paid in lives.

The experience of every other country that has achieved universal coverage — and the specific lesson that partial reforms, in a system as captured by industry interests as the American one, tend to be absorbed and neutralized rather than extended. The ACA's passage in 2010 — a reform far more modest than what its architects initially envisioned — required stripping out the public option, accepting industry-friendly provisions on drug pricing, and still faced near-unified Republican opposition and a Supreme Court challenge that allowed states to opt out of Medicaid expansion. Twelve states declined Medicaid expansion for over a decade, leaving millions of low-income adults in a coverage gap. The pattern — ambitious reform compromised to gain passage, then further eroded in implementation and subject to persistent rollback efforts — is precisely what single-payer advocates warned would happen. They are protecting the argument that incremental reform in a system this thoroughly captured does not build toward transformation; it stabilizes the status quo while producing the political appearance of progress.

What public option advocates are protecting

The practical recognition that 154 million Americans receive health coverage through their employers, that many of them are satisfied with that coverage, and that a reform which eliminates something that most people currently have — even to replace it with something better — will face political opposition sufficient to defeat it and may produce short-term disruption severe enough to harm the people it aims to help. The public option was developed as a policy tool precisely because its architects — most prominently Yale political scientist Jacob Hacker, who proposed the idea in 2001 — understood that any reform eliminating employer-based insurance would require displacing a system that a majority of Americans were familiar with and attached to. Hacker's insight was that a public option could achieve most of the coverage gains of single-payer while allowing the private system to continue for those who preferred it. The government plan would compete with private insurers on price and quality. Over time, its lower administrative costs and larger risk pool would draw more enrollees. The transition would be voluntary rather than mandatory. What this position protects is a genuine insight about political economy: policies are not only judged on their merits but on the losses they impose on people who currently have something, even an imperfect something. A reform that can pass and be implemented is worth more than a superior reform that cannot. In cluster terms, the public-option position is trying to create a more universal obligation without requiring the country to exit market governance all at once.

The claim that market competition, if structured correctly, can exert downward pressure on costs in ways that a purely governmental system might not — and that retaining private insurers as competitors preserves some of the innovation and responsiveness that government bureaucracies can struggle to produce. Public option advocates generally do not believe that private insurance is inherently more efficient than public insurance — the administrative cost differential makes that argument difficult. But they argue that competition between a public plan and private insurers creates pressure on private insurers to reduce administrative overhead, improve service, and lower premiums to retain enrollees. The Medicare Advantage program — under which private insurers offer Medicare benefits to seniors — is both an example and a cautionary tale: private insurers have used their market position to attract lower-cost enrollees and have lobbied successfully for overpayment relative to traditional Medicare, but the program has also demonstrated consumer demand for supplemental benefits and care coordination that traditional Medicare did not offer. Public option advocates are protecting the possibility that a mixed system — if the rules are written correctly — can be more adaptive than either a pure market or a pure government monopoly.

The political viability argument — that a public option can be constructed to win enough votes in a polarized legislative environment to actually become law, and that the perfect should not be the enemy of the coverage-expanding good. The Medicare for All Act has been introduced in every Congress since 2003 and has never come to a floor vote in either chamber. In the 119th Congress, it had 111 House co-sponsors — more than half of House Democrats — but zero Republican co-sponsors and faces certain opposition in the Senate. A public option, by contrast, was included in the House-passed version of the ACA and came close to passage in 2009. The political environment for any major healthcare reform has, if anything, become more difficult since then. Public option advocates point to this legislative reality not as a concession to bad political incentives but as recognition that democratic governance requires building coalitions, and that a reform with a path to enactment matters more to the people who need coverage than a reform whose moral clarity is matched by its political impossibility.

What market-based reformers are protecting

The evidence that when consumers face actual price signals in healthcare decisions, they make cost-effective choices — and that the fundamental problem with the American system is not that it is too market-based but that healthcare markets are so thoroughly distorted by third-party payment, regulatory barriers, and information asymmetries that competition cannot function as it does in other sectors. The Heritage Foundation and American Enterprise Institute have long argued that the United States does not have a genuine healthcare market — it has a system of government-mandated third-party payment that insulates consumers from price signals, insulates providers from competitive pressure, and produces the overutilization and administrative complexity that drives costs upward. Consumer-directed health plans — high-deductible plans paired with health savings accounts — put more spending decisions in consumers' hands and generate evidence that consumers do reduce discretionary healthcare use in response to cost-sharing. A RAND Health Insurance Experiment study found that people in plans with higher cost-sharing used about 30 percent less care than those with free care, with generally similar health outcomes except among the poor and sick. Market reformers are protecting the claim that cost-consciousness is not an obstacle to good healthcare but a necessary condition for it — that a system in which no one faces the cost of their decisions will always spend more than is medically optimal.

The specific concern that government-run or government-administered healthcare will suppress the innovation, investment, and competitive dynamism that has made the United States the origin of many of the world's most significant medical advances — and that universal coverage purchased at the cost of medical stagnation is a poor bargain. The United States originates a disproportionate share of new pharmaceutical compounds, medical devices, and treatment protocols relative to its share of the world's population or GDP. Critics of this claim note that basic research is publicly funded through the NIH regardless of the insurance structure, and that most breakthrough discoveries originate in academic labs rather than commercial ones. But market reformers point to the speed with which the U.S. system translates new discoveries into available treatments — and to countries with single-payer systems that negotiate stringent price controls, sometimes delaying availability of new drugs by years relative to the U.S. market. They are protecting the proposition that the American premium — paying more in the short run — subsidizes the discovery pipeline on which the whole world eventually benefits, and that dismantling it carries medical costs that do not appear in the coverage statistics.

The argument from individual liberty: that healthcare, however essential, is a service — and that mandating how it is purchased, what coverage must include, and which providers may participate in which networks is a form of coercion that a government committed to individual freedom should approach with caution. This argument is often caricatured as indifference to the uninsured. In its strongest form, it is something more considered: that the American tradition of limiting government power reflects hard-won experience with what governments do when their mandates are broad and their constituents' options are narrow. Market reformers at the Heritage Foundation originally proposed the individual mandate that later became the centerpiece of the ACA — and later repudiated it, not because healthcare access doesn't matter but because the mandate interacted with coverage requirements to produce a system that was less competitive and more bureaucratic than they intended. What this position protects is the institutional knowledge that government programs, once established, tend to expand their mandates and restrict the alternatives — and that healthcare, as one of the largest sectors of the economy, represents a very large bet on the competence and accountability of any government that administers it.

What ACA-framework defenders are protecting

The specific achievement of covering 24 million additional Americans through Medicaid expansion and marketplace subsidies without eliminating the employer-based system that most working Americans depend on — and the recognition that this achievement is fragile and reversible rather than a foundation to build on. The Affordable Care Act is not universally loved, even by its architects. It is a hybrid of regulated private markets, public program expansion, and individual mandate — designed by people who knew they were writing legislation that had to survive a filibuster, a constitutional challenge, and a hostile administrative environment after passage. Its achievements are real: the uninsured rate fell from about 18 percent before the ACA to about 7.7 percent in 2023 — the lowest in American history. Its Medicaid expansion brought coverage to adults who had previously been excluded. Its marketplaces created individual coverage for people who had been uninsurable due to pre-existing conditions. ACA defenders are not arguing that the law is optimal — they are protecting the recognition that 24 million people have coverage they did not have before, that dismantling what exists to build something better would require legislative majorities that do not currently exist, and that the gap between a policy's theoretical merits and its political durability is a political fact, not a moral failure. The obligation, on this view, is real but can be routed through subsidies, mandates, and public backstops rather than through a full replacement of the private insurance layer.

The specifically American experience with Medicaid expansion as proof that a significant increase in coverage can be achieved through existing federal-state infrastructure — and the related argument that building from what exists is less disruptive and politically more achievable than designing a new system from scratch. States that expanded Medicaid showed measurable improvements in coverage among low-income adults, reductions in uncompensated care at hospitals, and some evidence of improved health outcomes including reduced mortality. A 2019 study in JAMA Internal Medicine estimated that Medicaid expansion states had 6.1 percent lower mortality among low-income adults relative to non-expansion states over the study period. ACA framework defenders argue that this is what path-dependent reform looks like: imperfect coverage expanding through existing institutions in ways that reduce harm now, rather than waiting for a structural overhaul that may never achieve the political conditions for passage. They are protecting the principle that the test of a health policy is not its elegance but the number of people it keeps alive and solvent.

The argument from international comparison: that the most successful universal coverage systems in the world — Germany, Switzerland, the Netherlands — are not single-payer systems but highly regulated multi-payer systems in which private insurers compete under rules that prohibit cherry-picking, require community rating, and mandate minimum benefit packages that ensure genuine universality. Germany's social health insurance system (Gesetzliche Krankenversicherung) covers approximately 90 percent of the population through over 100 competing non-profit insurance funds, with a separate regulated market for private insurers covering the remaining 10 percent — primarily higher earners who can opt out. Switzerland mandates individual coverage through private insurers offering standardized basic benefit packages, with government subsidies for those who cannot afford premiums. Both systems achieve universal or near-universal coverage at lower cost than the United States without eliminating private insurance. ACA framework defenders are protecting the argument that the choice is not between the current American system and single-payer — that a third path, a heavily regulated multi-payer system with genuine universal coverage mandates, has been demonstrated to work in multiple countries and could serve as a realistic destination for American reform.